A clinical trial led by Neeraj Agarwal, MD, FASCO, found that a combination prostate cancer therapy could slow disease progression for patients with certain gene alterations, including BRCA.
Clinical Trial Shows Novel Prostate Cancer Treatment Can Reduce Risk of Disease Progression by Half
Huntsman Cancer Institute at the University of Utah